William A. Parker

2.2k total citations · 1 hit paper
83 papers, 1.2k citations indexed

About

William A. Parker is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, William A. Parker has authored 83 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 30 papers in Surgery and 16 papers in Internal Medicine. Recurrent topics in William A. Parker's work include Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Atrial Fibrillation Management and Outcomes (13 papers). William A. Parker is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Atrial Fibrillation Management and Outcomes (13 papers). William A. Parker collaborates with scholars based in United Kingdom, Canada and United States. William A. Parker's co-authors include Robert F. Storey, Aleksandra Gąsecka, Josip A. Borovac, Rui Guerreiro, Michela Giustozzi, Ramzi Ajjan, Panteleimon Ε. Papakonstantinou, Daniel Caldeira, Gemma Chiva‐Blanch and Dario Bongiovanni and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

William A. Parker

77 papers receiving 1.2k citations

Hit Papers

Current and novel biomarkers of thrombotic risk in COVID-... 2022 2026 2023 2024 2022 50 100 150

Peers

William A. Parker
Raktim K. Ghosh United States
Vardhmaan Jain United States
Tarek Kashour Saudi Arabia
Raktim K. Ghosh United States
William A. Parker
Citations per year, relative to William A. Parker William A. Parker (= 1×) peers Raktim K. Ghosh

Countries citing papers authored by William A. Parker

Since Specialization
Citations

This map shows the geographic impact of William A. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Parker more than expected).

Fields of papers citing papers by William A. Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Parker. The network helps show where William A. Parker may publish in the future.

Co-authorship network of co-authors of William A. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Parker. A scholar is included among the top collaborators of William A. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Parker. William A. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamargo, Juan, Stefan Agewall, Giuseppe Ambrosio, et al.. (2025). New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024. European Heart Journal - Cardiovascular Pharmacotherapy. 11(3). 292–317. 3 indexed citations
2.
Papakonstantinou, Panteleimon Ε., José Miguel Rivera‐Caravaca, Mauro Chiarito, et al.. (2025). Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?. Trends in Cardiovascular Medicine. 35(5). 271–281. 6 indexed citations
3.
Parker, William A. & Robert F. Storey. (2024). Oral anticoagulation and non-steroidal anti-inflammatory drugs: a recipe for bleeding. European Heart Journal. 46(1). 69–71. 2 indexed citations
4.
Parker, William A., Dominick J. Angiolillo, Fabiana Rollini, et al.. (2023). Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes. Vascular Pharmacology. 149. 107145–107145. 2 indexed citations
5.
Parker, William A. & Robert F. Storey. (2023). The role of platelet P2Y12 receptors in inflammation. British Journal of Pharmacology. 181(4). 515–531. 9 indexed citations
6.
Nelson, Thomas A., J. David Richardson, Arvindra Krishnamurthy, et al.. (2023). 71 Initial clinical experience with 6-hour enoxaparin regimen in opiate-treated patients undergoing primary percutaneous coronary intervention. A81.1–A81. 1 indexed citations
7.
Parker, William A., et al.. (2021). Improving the timely availability of blood products for patients undergoing craniosynostosis surgery. Perioperative Care and Operating Room Management. 25. 100207–100207. 1 indexed citations
8.
Giustozzi, Michela, Dario Bongiovanni, Josip A. Borovac, et al.. (2021). Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment. Blood Reviews. 50. 100864–100864. 102 indexed citations
9.
Parker, William A., et al.. (2021). Case series of acute appendicitis association with SARS-CoV-2 infection. BMC Infectious Diseases. 21(1). 217–217. 7 indexed citations
10.
Parker, William A. & Javaid Iqbal. (2020). Comparison of Contemporary Drug-eluting Coronary Stents – Is Any Stent Better than the Others?. Heart International. 14(1). 34–34. 10 indexed citations
11.
Parker, William A. & Robert F. Storey. (2020). Novel approaches to P2Y 12 inhibition and aspirin dosing. Platelets. 32(1). 7–14. 11 indexed citations
12.
Gąsecka, Aleksandra, Josip A. Borovac, Rui Guerreiro, et al.. (2020). Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovascular Drugs and Therapy. 35(2). 215–229. 107 indexed citations
13.
Parker, William A., et al.. (2020). Acoustic shock: an update review. The Journal of Laryngology & Otology. 134(10). 848–853. 1 indexed citations
14.
Parker, William A., et al.. (2019). Chest wall pain following lung stereotactic body radiation therapy using 48 Gy in three fractions: A search for predictors. Cancer/Radiothérapie. 23(2). 98–103. 2 indexed citations
15.
Coen, John J., Peixin Zhang, Philip J. Saylor, et al.. (2018). Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial. Journal of Clinical Oncology. 37(1). 44–51. 97 indexed citations
16.
Parker, William A., et al.. (2018). ULTRA-LOW-DOSE TWICE-DAILY ASPIRIN IMPROVES HEMOSTASIS AND MAINTAINS PLATELET INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS RECEIVING TICAGRELOR. Journal of the American College of Cardiology. 71(11). A30–A30. 1 indexed citations
17.
Parker, William A., Ovie Edafe, & Sabapathy P. Balasubramanian. (2017). Long-term treatment-related morbidity in differentiated thyroid cancer: a systematic review of the literature. PubMed. Volume 8. 57–67. 20 indexed citations
18.
Patel, Samir, T. Vuong, Olivier Ballivy, et al.. (2004). Phase II trial of pelvic intensity-modulated radiotherapy (IMRT) with concurrent chemotherapy for patients with rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 60(1). S424–S425. 6 indexed citations
19.
Parker, William A.. (1979). The Compendium of Pharmaceuticals and Specialties as a Drug Information Resource for Treatment of Acute Drug Overdose. Canadian Family Physician. 25. 211–215. 5 indexed citations
20.
Parker, William A., et al.. (1951). PREGNANCY AND COARCTATION OF THE AORTA. BJOG An International Journal of Obstetrics & Gynaecology. 58(2). 291–292. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026